ArticleThe oncologist2025

Impact of carboplatin schedule on pCR in a modified KEYNOTE-522 regimen with dose-dense AC for triple negative breast cancer.

Kennedi G Satterfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.